Quick Answer
Outset Medical, Inc. reported Long Term Debt of $96.24 million for the year ending 2025.
- Outset Medical, Inc. showed a decrease of -51.2% in Long Term Debt from 2024 to 2025.
- This data is from Outset Medical, Inc.'s annual report (Form 10-K), filed with the SEC on February 13, 2026.
- XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2020: $29.65 million | Q1 2021: $29.70 million | Q2 2021: $29.72 million | Q3 2021: $29.74 million | Q1 2022: $29.78 million | Q2 2022: $28.81 million | Q3 2022: $29.83 million | Q1 2023: $96.48 million | Q2 2023: $96.63 million | Q3 2023: $96.78 million | Q1 2024: $196.81 million | Q2 2024: $196.99 million | Q3 2024: $197.18 million | Q1 2025: $94.12 million | Q2 2025: $94.81 million | Q3 2025: $95.52 million.
- Over the full 7 years of available data (2019 to 2025), Outset Medical, Inc.'s Long Term Debt has grown by 346.3%.
- Historical annual values: Fiscal year 2025: $96.24 million | Fiscal year 2024: $197.38 million | Fiscal year 2023: $130.11 million | Fiscal year 2022: $96.34 million | Fiscal year 2021: $29.76 million | Fiscal year 2020: $29.67 million | Fiscal year 2019: $21.56 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: